

THOMAS BEPNER
The session “Strategies to Deliver Optimal Dose of
Dialysis” was opened with a lecture by Professor Bernard Charra, MD, who argued that “length of
time on dialysis is more important than Kt/V.” He began with a review of his experience in
Tassin, France, with slow prolonged hemodialysis using conventional membranes and acetate
dialysate. He showed that the mix of patients has changed in recent years to include a higher
percentage of older patients and patients with diabetes (20%) and other comorbid diseases. As a
consequence, the prolonged average survival rate reported from his clinic has fallen
dramatically, as shown by Kaplan–Meier analysis, but he has continued to maintain some of his
patients for many years using slow prolonged dialysis three times weekly.
More recently, he compared 8-hour with 5-hour dialyses and found that mean arterial
pressures were more easily maintained in the normal range, and that the incidence of
hypotension during dialysis was much less frequent, with 8-hour treatments. In all patients,
better survival was observed in those whose mean arterial pressures were better controlled. Dr.
Charra proposed that the vicious cycle of short dialysis was the explanation for the benefit of
prolonged dialysis. As dialysis time is shortened, fluid removal rates must be increased,
leading to more frequent hypotension and cramps during the treatment. The physician responds by
shortening the dialysis even further, by increasing the dialysate sodium concentration, and by
treating cramps with hypertonic saline. The physician may also increase the target weight. This
leads to increased thirst and hypertension between dialyses, essentially negating the efforts of
the physician and, in many cases, promoting further fluid gain. The patient experiences an
increased incidence of cramps and hypotension (observed more in his 5-hour-dialysis patients),
and worsening control of blood pressure. Dr. Charra acknowledged that increasing Kt/V is
beneficial but he feels, based on these experiences, that increasing time on dialysis is
preferable to increasing the clearance rate.
Another proponent of prolonged dialysis, but on a daily basis, Andreas Pierratos, MD, Humber
River Regional Hospital, Toronto, Ontario, reviewed the latest experience with prolonged
nighttime dialysis in Toronto. He echoed the improved hemodynamic stability voiced by Dr. Charra
in comparisons of standard with nocturnal hemodialysis, and noted that neither remote monitoring
nor a partner were required for his patients dialyzed at home. Most patients were maintained
with central lines because they were dialyzed at home, but increasingly more are managing with
peripheral arteriovenous fistulas, using cannulas properly secured to prevent accidental
dislodgment. Catheter infections were not increased and he continued to note the near complete
absence of exit-site infections, an observation that is unexplained. He warned about the loss of
calcium and phosphate in the dialysate due to prolonged daily treatments, and advised increasing
calcium concentrations and adding phosphate to the dialysate. In general, his patients do not
require phosphate binders. Other benefits of prolonged nighttime dialysis include the use of
marginal fistulas (since high blood flow rates are not required), decreased erythropoietin
requirements resulting in a considerable cost savings, improved cognitive functions documented
by objective testing, improved quality of life, and improvement in sleep apnea.
Taking a somewhat opposite point of view, Robert Lindsay, MD, from London Health Sciences
Centre, London, Ontario, explained that his dialysis center has embarked upon a study (funded by
the Canadian government) of short versus prolonged daily hemodialysis. This study has just begun
so he is not in a position to recommend either therapy, but is attempting to remain objective
and to select a mix of patients with preferences for one or the other treatment. He will compare
outcomes and other measures in these two groups and examine similar parameters in a cohort of
patients currently dialyzed on the standard three-per-week schedule. Dr. Lindsay noted that the
first few patients treated with prolonged daily dialysis developed increases in serum
bicarbonate concentration, requiring adjustment of bicarbonate in the dialysate. He also noted
that serum phosphorus concentration remained unchanged until after the first month of dialysis,
when it began to fall. He plans to monitor access blood flow and access survival as part of
this study. 